Han-Guang Yan Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

12/2007

Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han-Guang Yan Research Topics

Disease

2	Tuberculosis (Tuberculoses) 11/2014 - 06/2012
1	Infections 06/2012
1	Sarcoma (Soft Tissue Sarcoma) 12/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2007
1	Lung Neoplasms (Lung Cancer) 12/2007
1	Neoplasms (Cancer) 12/2007

Drug/Important Bio-Agent (IBA)

1	Anti-Bacterial Agents (Antibiotics)IBA 11/2014
1	TrehaloseIBA 06/2012
1	Cord FactorsIBA 06/2012
1	AerosolsIBA 06/2012
1	cyclopropaneIBA 06/2012
1	Protein Kinases (Protein Kinase)IBA 12/2007
1	Sirolimus (Rapamycin)FDA Link 12/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2007
1	TOR Serine-Threonine KinasesIBA 12/2007
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 12/2007
1	mirdametinibIBA 12/2007
1	ridaforolimusIBA 12/2007